EPO and Parkinson disease: We have recently shown that intrastriatal injections of AAV9 carrying a human erythropoietin (hEPO) gene result in a robust hEPO transduction in the striatum and protect nigral DA neurons from 6-hydroxydopamine (6-OHDA) toxicity in a rat model of PD, suggesting its therapeutic potential for PD [12].